These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Resistant hypertension revisited: a comparison of two university-based cohorts. Garg JP, Elliott WJ, Folker A, Izhar M, Black HR, RUSH University Hypertension Service. Am J Hypertens; 2005 May; 18(5 Pt 1):619-26. PubMed ID: 15882544 [Abstract] [Full Text] [Related]
5. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. McAdam-Marx C, Ye X, Sung JC, Brixner DI, Kahler KH. Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112 [Abstract] [Full Text] [Related]
6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [Abstract] [Full Text] [Related]
7. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM. Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [Abstract] [Full Text] [Related]
13. Treatment of hypertension in chronic kidney disease. Toto RD. Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [Abstract] [Full Text] [Related]
14. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment. Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E. Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481 [Abstract] [Full Text] [Related]
15. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug. Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M. Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208 [Abstract] [Full Text] [Related]
16. Effect of pharmacist intervention on control of resistant hypertension. Morse GD, Douglas JB, Upton JH, Rodgers S, Gal P. Am J Hosp Pharm; 1986 Apr; 43(4):905-9. PubMed ID: 3706334 [Abstract] [Full Text] [Related]
17. Retrospective review of the medical records of cardiology hospital outpatient clinics with the aim of determining the therapeutic approach to patients suffering from high blood pressure and/or dyslipidemia. Rato Q, Cardoso AA. Rev Port Cardiol; 2006 Oct; 25(10):889-905. PubMed ID: 17190239 [Abstract] [Full Text] [Related]
20. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension. Germino FW. Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484 [Abstract] [Full Text] [Related] Page: [Next] [New Search]